Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-001332
Filing Date
2025-01-10
Accepted
2025-01-10 20:00:36
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 form4a-01102025_080133.html 4/A  
1 form4a-01102025_080133.xml 4/A 3126
  Complete submission text file 0001415889-25-001332.txt   4753
Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
Brazzell Romulus K (Reporting) CIK: 0001298079 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38150 | Film No.: 25524426

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)